Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2013 Dec 14;274(3):372–382. doi: 10.1016/j.taap.2013.11.023

Table 1. Viability of DZ or DZO-treated astrocytes.

Viability (% ± SEM)
Concentration
(μM)
DZ DZO
0 100 100
1 101.2 ± 7.9 100.8 ± 6.5
5 104.3 ± 5.1 97.5 ± 1.8
10 106.0 ± 8.0 91.4 ± 2.2
25 104.3 ± 6.8 98.2 ± 3.2
50 114.5 ± 8.1 99.1 ± 2.1

Astrocytes were treated with varying concentrations of either DZ or DZO for 24 h and cell viability was assessed by the MTT method. Results are expressed as percent control (mean ± SEM) and are from three separate experiments where astrocytes where treated in triplicate.